Dr Reddy’s Q2 Profit Falls 36%; Semaglutide Relaunch Planned for November
Dr Reddy’s Laboratories reported September-quarter profit of Rs.925 crore, down 36% year on year, and consolidated revenue of Rs.8,671 crore, down 1.5%. The company plans to relaunch semaglutide in November.